Evidence for the role of calcineurin in morphogenesis and calcium homeostasis during mycelium-to-yeast dimorphism of Paracoccidioides brasiliensis.
Paracoccidioides brasiliensis is a dimorphic fungus that causes paracoccidioidomycosis, the most prevalent human deep mycosis in Latin America. The dimorphic transition from mycelium to yeast (M-Y) is triggered by a temperature shift from 25 degrees C to 37 degrees C and is critical for pathogenicity. Intracellular Ca(2+) levels increased in hyphae immediately after temperature-induced dimorphism. The chelation of Ca(2+) with extracellular (EGTA) or intracellular (BAPTA) calcium chelators inhibited temperature-induced dimorphism, whereas the addition of extracellular Ca(2+) accelerated dimorphism. The calcineurin inhibitor cyclosporine A (CsA), but not tacrolimus (FK506), effectively decreased cell growth, halted the M-Y transition that is associated with virulence, and caused aberrant growth morphologies for all forms of P. brasiliensis. The difference between CsA and FK506 was ascribed by the higher levels of cyclophilins contrasted to FKBPs, the intracellular drug targets required for calcineurin suppression. Chronic exposure to CsA abolished intracellular Ca(2+) homeostasis and decreased mRNA transcription of the CCH1 gene for the plasma membrane Ca(2+) channel in yeast-form cells. CsA had no detectable effect on multidrug resistance efflux pumps, while the effect of FK506 on rhodamine excretion was not correlated with the transition to yeast form. In this study, we present evidence that Ca(2+)/calmodulin-dependent phosphatase calcineurin controls hyphal and yeast morphology, M-Y dimorphism, growth, and Ca(2+) homeostasis in P. brasiliensis and that CsA is an effective chemical block for thermodimorphism in this organism. The effects of calcineurin inhibitors on P. brasiliensis reinforce the therapeutic potential of these drugs in a combinatory approach with antifungal drugs to treat endemic paracoccidioidomycosis.
Campos
Claudia B L
CB
Instituto de Pesquisa e Desenvolvimento, Universidade do Vale do Paraiba, Urbanova, Sao Paulo, Brazil. cbcampos@univap.br
Di Benedette
Joao Paulo T
JP
Morais
Flavia V
FV
Ovalle
Rafael
R
Nobrega
Marina P
MP
D019703:Calcineurin / Q000235:genetics / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism*; D016572:Cyclosporine / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005656:Fungal Proteins / Q000235:genetics / Q000378:metabolism*; D015966:Gene Expression Regulation, Fungal / Q000187:drug effects; D006706:Homeostasis / Q000187:drug effects; D006801:Humans; D009024:Morphogenesis / Q000187:drug effects; D025282:Mycelium / Q000201:enzymology / Q000235:genetics / Q000254:growth & development / Q000378:metabolism; D010228:Paracoccidioides / Q000201:enzymology* / Q000235:genetics / Q000254:growth & development* / Q000378:metabolism; D010229:Paracoccidioidomycosis / Q000188:drug therapy / Q000382:microbiology; D016559:Tacrolimus / Q000494:pharmacology; D013696:Temperature
D004791:Enzyme Inhibitors; D005656:Fungal Proteins; D016572:Cyclosporine; D019703:Calcineurin; D002118:Calcium; D016559:Tacrolimus
EMBO J. 1997 May 15;16(10):2576-89
9184205
Med Mycol. 2002 Jun;40(3):225-42
12146752
Biochem Biophys Res Commun. 2003 Nov 28;311(4):1143-50
14623300
Eukaryot Cell. 2008 Feb;7(2):177-86
18065652
Biochemistry. 1996 Jan 16;35(2):562-6
8555228
Genet Mol Res. 2005 Jun 30;4(2):346-57
16110450
J Biol Chem. 2002 Aug 23;277(34):31079-88
12058033
Antimicrob Agents Chemother. 2003 Mar;47(3):956-64
12604527
FEBS Lett. 2005 Oct 24;579(25):5697-703
16223494
Expert Opin Pharmacother. 2005 Mar;6(3):385-97
15794730
Mol Microbiol. 2003 May;48(4):959-76
12753189
Physiol Rev. 2000 Oct;80(4):1483-521
11015619
J Med Vet Mycol. 1987 Feb;25(1):5-18
3553526
Antimicrob Agents Chemother. 2007 Aug;51(8):2979-81
17502415
Mol Gen Genet. 1997 Sep;256(2):104-14
9349701
Anticancer Res. 1992 Jan-Feb;12(1):21-5
1373592
Eukaryot Cell. 2003 Jun;2(3):422-30
12796287
Infect Immun. 2005 Sep;73(9):5767-74
16113294
Mol Cell Biol. 1995 Aug;15(8):4103-14
7542741
EMBO J. 2001 Mar 1;20(5):1020-32
11230126
Fungal Genet Biol. 2003 Aug;39(3):204-10
12892633
Mycopathologia. 1985 Dec;92(3):173-8
4088290
Eukaryot Cell. 2006 Oct;5(10):1788-96
16950930
Mol Cell Biol. 1997 Nov;17(11):6339-47
9343395
Curr Drug Targets. 2006 Apr;7(4):471-81
16611035
EMBO J. 2002 May 15;21(10):2343-53
12006487
Mol Genet Genomics. 2001 Dec;266(4):527-36
11810223
Nature. 1989 Oct 26;341(6244):758-60
2477715
Science. 2006 Apr 28;312(5773):583-8
16645097
Nat Rev Microbiol. 2007 Jun;5(6):418-30
17505522
Genome Biol. 2005;6(7):226
15998457
Methods. 2001 Dec;25(4):402-8
11846609
Eukaryot Cell. 2008 Feb;7(2):415-24
18083828
Fungal Genet Biol. 2007 Mar;44(3):219-30
16990036
J Clin Microbiol. 2000 Nov;38(11):3960-6
11060052
Arch Med Res. 1995 Autumn;26(3):305-6
8580685
Proc Natl Acad Sci U S A. 1990 Jun;87(11):4028-32
2190212
Eukaryot Cell. 2005 Dec;4(12):2115-28
16339729
Nature. 1989 Feb 2;337(6206):473-5
2644542